Ozenoxacin Impurity 2 | CAS 103877-51-6 - Request Quote
Ozenoxacin Impurity 2
| SZ CAT No: | SZ-O023006 |
| CAS No | 103877-51-6 |
| Mol.F. | C16H16ClNO3 |
| Mol.Wt. | 305.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Ozenoxacin Impurity 2 is chemically Ethyl 7-chloro-1-cyclopropyl-8-methyl-4-oxo-1,4-dihydroquinoline-3-carboxylate. Ozenoxacin Impurity 2 is supplied with detailed characterization data compliant with regulatory guideline. Ozenoxacin Impurity 2 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Ozenoxacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 103877-51-6
Purchase 103877-51-6
Order 103877-51-6
Enquire 103877-51-6
price of 103877-51-6
103877-51-6 Supplier
103877-51-6 Manufacturer
103877-51-6 Exporter
buy high quality Ozenoxacin Impurity 2
Purchase Ozenoxacin Impurity 2
Ozenoxacin Impurity 2 suppliers
Ozenoxacin Impurity 2 manufacturers
Ozenoxacin Impurity 2 price
Order Ozenoxacin Impurity 2
Enquire Ozenoxacin Impurity 2
Ozenoxacin Impurity 2 cost
Ozenoxacin Impurity 2 Supplier
Ozenoxacin Impurity 2 Distributor
Ozenoxacin Impurity 2 for Method Validation
Ozenoxacin Reference Standard
Ozenoxacin Impurity 2 for ANDA Filing
Ozenoxacin Impurity 2 for Forced Degradation Studies
Ozenoxacin Impurity 2 Identification Standards
Ozenoxacin Impurity 2 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.